Day: June 18, 2024

Cannabix Technologies Annual General and Special Meeting Results

Cannabix Technologies Annual General and Special Meeting Results

VANCOUVER, British Columbia, June 18, 2024 (GLOBE NEWSWIRE) — Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (the “Company”) announces the results of its annual general and special meeting of common shareholders held on June 18, 2024 in Vancouver. Resolutions passed at the meeting included the appointment of Saturna Group Chartered Accountants LLP as auditors for the ensuing year, an ordinary resolution to approve the adoption of the Company’s Stock Option Incentive Plan and the granting of stock options thereunder in an amount up to 15% of the total issued and outstanding shares, an ordinary resolution to approve the adoption of the Company’s Restricted Share Unit Incentive Plan and the granting of equity awards thereunder in an amount up to 5% of the total issued and outstanding shares, and the election of Dr. Raj Attariwala,...

Continue reading

Northview Residential REIT Announces Results of Voting For Trustees at Annual Meeting of Unitholders

Northview Residential REIT Announces Results of Voting For Trustees at Annual Meeting of Unitholders

Not for distribution to U.S. newswire services or for dissemination in the United States. CALGARY, Alberta, June 18, 2024 (GLOBE NEWSWIRE) — Northview Residential REIT (the “REIT”) (TSX: NRR.UN) today announced the results of voting at its annual meeting of unitholders held earlier today (the “Meeting”). Each of the nominees listed in the management information circular dated May 3, 2024 was elected as a trustee of the REIT at the Meeting. On a vote conducted by ballot, the voting results were as follows: Nominee # of Votes For % of Votes For # of Votes Withheld % of Votes Withheld Todd Cook 23,505,748 99.742% 60,724 0.258% Daniel Drimmer 22,907,222 97.203% 659,250 2.797% Rob Kumer 23,501,544 99.724% 64,928 0.276% Harry Rosenbaum 23,505,628 99.742% 60,844 0.258% Kelly Smith 23,501,664 99.725% 64,808 0.275% Lawrence...

Continue reading

Fairfax Announces Pricing of Senior Notes Offering and Re-Opening of 6.000% Senior Notes Due 2033

Fairfax Announces Pricing of Senior Notes Offering and Re-Opening of 6.000% Senior Notes Due 2033

TORONTO, June 18, 2024 (GLOBE NEWSWIRE) — Fairfax Financial Holdings Limited (“Fairfax”) (TSX: FFH and FFH.U) announces that it has priced a private offering of US$600,000,000 of senior notes due 2055 (the “New Notes”) at an issue price of 99.585% and a private offering of an additional US$150,000,000 of its 6.000% senior notes due December 7, 2033 (the “Additional 2033 Notes” and, together with the New Notes, the “Notes”) at an issue price of 102.697%, plus accrued interest. The New Notes will be unsecured obligations of Fairfax and will pay a fixed rate of interest of 6.100% per annum. Fairfax currently has outstanding US$600,000,000 aggregate principal amount of its 6.000% senior notes due 2033 (the “Original 2033 Notes”). The Additional 2033 Notes will have the same terms as the Original 2033 Notes, except for the issue date,...

Continue reading

NioBay Applauds Phosphorous Critical Minerals Classification

NioBay Applauds Phosphorous Critical Minerals Classification

MONTRÉAL, June 18, 2024 (GLOBE NEWSWIRE) — NioBay Metals Inc. (“NioBay” or the “Company”) (TSX-V: NBY) (OTCQB: NBYCF) is satisfied with the update to Canada’s list of critical minerals announced by the Minister of Energy and Natural Resources, Jonathan Wilkinson. Additionally, NioBay is pleased that tantalum and niobium, which were already on this list, will now provide additional tax credits. There are 34 minerals on the list, which now includes high-purity iron ore, phosphorus, and silicon metal. All are deemed essential to the development of clean technologies and in various industries like microchips, green steel, and lithium-iron-phosphate batteries. This update aims to strengthen critical minerals value chains to support Canada’s energy and economic transition. Critical minerals are fundamental to modern products and...

Continue reading

Tempest to Report New Data from Global Randomized Combination Study of Amezalpat (TPST-1120) in First-Line Hepatocellular Carcinoma

Tempest to Report New Data from Global Randomized Combination Study of Amezalpat (TPST-1120) in First-Line Hepatocellular Carcinoma

Webcasted conference call on Thursday, June 20, 2024 at 8:30 a.m. ET BRISBANE, Calif., June 18, 2024 (GLOBE NEWSWIRE) — Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-classi targeted and immune-mediated therapeutics to fight cancer, today announced the company plans to report new data from the global randomized Phase 1b/2 combination study of amezalpat (TPST-1120) with atezolizumab and bevacizumab in first-line treatment of hepatocellular carcinoma (HCC) in a premarket press release followed by a webcasted conference call with associated slide presentation on Thursday, June 20, 2024 at 8:30 a.m. ET. To join the conference call via phone and participate in the live Q&A session, please pre-register online here to receive a telephone number and unique passcode required to...

Continue reading

Andrew Peller Limited Reports Margin and Profit Growth for Fiscal 2024

Andrew Peller Limited Reports Margin and Profit Growth for Fiscal 2024

GRIMSBY, Ontario, June 18, 2024 (GLOBE NEWSWIRE) — Andrew Peller Limited (TSX:ADW.A / ADW.B) (“APL” or the “Company”) announced today results for the three and twelve months ended March 31, 2024. All amounts are expressed in Canadian dollars unless otherwise stated. FOURTH QUARTER 2024 HIGHLIGHTS Revenue was $85.0 million, up 9.4% compared with $77.7 million in the prior year; Gross margin increased to $35.6 million (41.8%) from $22.1 million (28.4%) in Q4 2023; EBITA increased to $9.3 million, from ($1.2 million) in Q4 2023; and Net loss of $6.9 million ($0.17 per Class A Share), compared with $10.0 million ($0.24 per Class A Share) in Q4 2023. FISCAL 2024 HIGHLIGHTS: Revenue of $385.9 million compared to $382.1 million in the prior year. Gross margin was 39.0%, up from 37.1% in the prior year; EBITA of $50.3 million, up 32.4%...

Continue reading

Euro Manganese Announces Completion of Commissioning of its Chvaletice High-purity Manganese Demonstration Plant

Euro Manganese Announces Completion of Commissioning of its Chvaletice High-purity Manganese Demonstration Plant

VANCOUVER, British Columbia, June 18, 2024 (GLOBE NEWSWIRE) — Euro Manganese Inc. (TSX-V and ASX: EMN; OTCQB: EUMNF; Frankfurt: E06) (the “Company” or “EMN”) is pleased to announce the successful completion of commissioning of its high-purity manganese Demonstration Plant at its Chvaletice Manganese Project (“Chvaletice” or the “Project”) in the Czech Republic. Highlights Two independent external laboratories have confirmed that samples of high-purity manganese sulphate monohydrate (“HPMSM”) made from high-purity electrolytic manganese metal (“HPEMM”) produced at the Demonstration Plant (“DP”) meet the DP design target HPMSM specifications with low levels of impurities. With all modules operating on a consistent basis, and producing on-spec products, this...

Continue reading

Black Hills Corp. Announces Leadership Change

Black Hills Corp. Announces Leadership Change

RAPID CITY, S.D., June 18, 2024 (GLOBE NEWSWIRE) — Black Hills Corp. (NYSE: BKH) today announced that Todd Jacobs, senior vice president of growth and strategy, has accepted a role with another company. July 8 is planned as his last day with Black Hills Corp. Since joining the company in 2014, Mr. Jacobs has held a variety of roles, including state leader of Kansas and Arkansas operations, vice president of natural gas utilities and vice president of growth and strategy. “Todd is a valued leader who has made a lasting impact on our organization,” said Linn Evans, Black Hills Corp. president and chief executive officer. “I wish him the very best and thank him for his ten years of service to our company and our customers.” Strong organizational leadership will ensure a smooth transition of Mr. Jacobs’ duties. Any future plans for...

Continue reading

Aptose Announces Results from Annual and Special Meeting of Shareholders

Aptose Announces Results from Annual and Special Meeting of Shareholders

SAN DIEGO and TORONTO, June 18, 2024 (GLOBE NEWSWIRE) — Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage precision oncology company developing highly differentiated oral kinase inhibitors to treat hematologic malignancies, today announced the voting results from the Company’s annual and special meeting of shareholders held today, June 18, 2024 (the “Meeting”). A total of 8,101,527 common shares of the Company, representing 49.67% of the common shares of the Company entitled to be voted, were represented by shareholders present or represented by proxy at the Meeting. The Company is pleased to announce that all of the nominees listed in the proxy statement dated May 14, 2024, were re-elected as Directors. The results of the vote are provided below: Nominee Votes Ms. Carol G. Ashe 4,959,150 Dr....

Continue reading

Gabelli Multimedia Trust Announces Rights Offering for Shares of Common Stock Record Date and Summary of Terms

Gabelli Multimedia Trust Announces Rights Offering for Shares of Common Stock Record Date and Summary of Terms

RYE, N.Y., June 18, 2024 (GLOBE NEWSWIRE) — The Board of Directors of The Gabelli Multimedia Trust Inc. (NYSE: GGT) (the “Fund”) has approved a transferable rights offering which would allow the Fund’s record date common shareholders to acquire additional shares of common stock (the “Offering”). The Offering will be made only by means of a prospectus supplement and accompanying prospectus, and this announcement does not constitute an offer to sell, or a solicitation of an offer to buy, any of the Fund’s securities. SUMMARY OF THE TERMS OF THE OFFERING Each shareholder will receive one transferable right (the “Right”) for each share of common stock held on the record date (June 28, 2024). The number of Rights to be issued to a shareholder as of the close of business on the record date will be rounded up to the nearest number of...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.